Clinical trials are required whenever GSK develops a new medicine. Patients are central to any clinical trial and every new medicine that GSK works on – we are always looking at ways in which GSK can improve the experience of patients taking part in clinical trials. GSK views patients as partners in every clinical trial and wants to explore ways of enhancing this partnership using new technologies and methodologies.
By their nature, clinical trials require patients to attend visits with their care team and generally have additional assessments on top of their normal appointments. GSK are looking to understand how we can minimise the burden of the clinical trial process for patients and enhance the patient experience of taking part in a clinical trial. In addition to minimising burden, GSK also wants to consider ways in which the clinical trial experience can be improved so that it is more engaging for patients – they can feel more a part of a larger research initiative than an individual. This should happen while the study adheres to the principles of Good Clinical Practice and other relevant regulations and guidelines.
Successful applicants with viable proposals with sufficient experience in the clinic will be invited to present their proposal to a group within GSK. Subsequently, if the idea is sufficiently mature with experience in clinical, there may be opportunities to scope a prototype within GSK and even to pilot the innovation within a GSK clinical study.